HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiangyi Meng Selected Research

Duration of Therapy

5/2014Impact of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod: Subgroup analyses of the Fingolimod Research Evaluating Effects of Daily Oral Therapy in Multiple Sclerosis (FREEDOMS) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiangyi Meng Research Topics

Disease

28Alzheimer Disease (Alzheimer's Disease)
05/2016 - 01/2008
16Multiple Sclerosis
11/2023 - 05/2014
12Psoriasis (Pustulosis Palmaris et Plantaris)
05/2022 - 12/2016
7Macular Degeneration (Age-Related Maculopathy)
02/2024 - 01/2021
7Dementia (Dementias)
10/2013 - 01/2010
6Schizophrenia (Dementia Praecox)
01/2015 - 09/2011
5Parkinson Disease (Parkinson's Disease)
09/2011 - 01/2010
4Relapsing-Remitting Multiple Sclerosis
10/2020 - 03/2015
3Neoplasms (Cancer)
10/2023 - 06/2015
3Infections
07/2022 - 01/2019
3Psychomotor Agitation (Akathisia)
01/2015 - 01/2012
2Hypertension (High Blood Pressure)
11/2023 - 07/2007
2Heart Failure
12/2022 - 01/2020
2Inflammation (Inflammations)
12/2022 - 01/2022
2Body Weight (Weight, Body)
05/2022 - 01/2015
2Pain (Aches)
11/2021 - 07/2019
2Psoriatic Arthritis
09/2021 - 01/2020
2Dizziness (Lightheadedness)
01/2015 - 01/2012
2Sleepiness
01/2015 - 01/2012
2Tachycardia (Tachyarrhythmias)
02/2013 - 01/2012
2Psychotic Disorders (Schizoaffective Disorder)
02/2013 - 01/2012
2Type 2 Diabetes Mellitus (MODY)
10/2011 - 01/2010
2Cognitive Dysfunction
09/2011 - 02/2009
1Seizures (Absence Seizure)
11/2023
1COVID-19
11/2023
1Severe Acute Respiratory Syndrome
11/2023
1Phototoxic Dermatitis (Phototoxicity)
10/2023
1Breast Neoplasms (Breast Cancer)
10/2023
1Glioma (Gliomas)
10/2023
1Mycoses (Diseases, Fungus)
01/2023
1Hypoalbuminemia
01/2023
1Pulmonary Heart Disease (Cor Pulmonale)
01/2023
1Cardiomyopathies (Cardiomyopathy)
12/2022
1Retinal Vasculitis
01/2022
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2022
1Aneurysm (Aneurysms)
01/2022
1Ankylosing Spondylitis
01/2020
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2019
1Human Influenza (Influenza)
11/2019
1Urinary Tract Infections (Urinary Tract Infection)
11/2019
1Pruritus (Itching)
07/2019
1Mobility Limitation (Difficulty Walking)
10/2018

Drug/Important Bio-Agent (IBA)

28Rivastigmine (Exelon)FDA LinkGeneric
05/2016 - 01/2008
14Fingolimod Hydrochloride (FTY720)FDA Link
07/2022 - 05/2014
12secukinumabIBA
05/2022 - 12/2016
6iloperidoneFDA Link
01/2015 - 09/2011
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2024 - 12/2021
5InterferonsIBA
12/2022 - 05/2014
5Cholinesterase Inhibitors (Anticholinesterases)IBA
12/2011 - 01/2008
4Capsules (Microcapsules)IBA
12/2011 - 01/2010
4Donepezil (Aricept)FDA LinkGeneric
01/2010 - 01/2008
3Retinaldehyde (Retinal)IBA
02/2024 - 01/2021
3Monoclonal AntibodiesIBA
11/2023 - 12/2016
3Glatiramer Acetate (Copaxone)FDA Link
10/2018 - 05/2014
3Antipsychotic Agents (Antipsychotics)IBA
01/2015 - 09/2011
3Risperidone (Risperdal Consta)FDA LinkGeneric
01/2015 - 01/2012
3A-factor (Streptomyces)IBA
01/2015 - 01/2010
3Memantine (Namenda)FDA Link
01/2015 - 02/2010
2sacubitril and valsartan sodium hydrate drug combinationIBA
12/2022 - 01/2020
2Biomarkers (Surrogate Marker)IBA
12/2022 - 12/2022
2Etanercept (Enbrel)FDA Link
05/2022 - 01/2017
2Immunoglobulin A (IgA)IBA
05/2022 - 01/2019
2Sphingosine-1-Phosphate ReceptorsIBA
01/2019 - 05/2014
2Aripiprazole (Abilify)FDA Link
01/2015 - 03/2014
2Olanzapine (Zyprexa)FDA Link
01/2015 - 03/2014
2ziprasidone (Geodon)FDA Link
02/2013 - 01/2012
2Antihypertensive Agents (Antihypertensives)IBA
10/2011 - 01/2010
2Valsartan (Vals)FDA Link
01/2010 - 07/2007
1TitaniumIBA
11/2023
1Immunoglobulin G (IgG)IBA
11/2023
1Messenger RNA (mRNA)IBA
11/2023
1mRNA VaccinesIBA
11/2023
1ofatumumabFDA Link
11/2023
11-phenyl-3,3-dimethyltriazene (PDT)IBA
10/2023
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2023
1avermectinIBA
10/2023
1doramectinIBA
10/2023
1Anti-Bacterial Agents (Antibiotics)IBA
01/2023
1Blood Glucose (Blood Sugar)IBA
01/2023
1ProcalcitoninIBA
01/2023
1Interleukin-6 (Interleukin 6)IBA
12/2022
1Mitogen-Activated Protein KinasesIBA
12/2022
1Caspase 3 (Caspase-3)IBA
12/2022
1bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
12/2022
1Interleukin-8 (Interleukin 8)IBA
12/2022
1NF-kappa B (NF-kB)IBA
12/2022
1Neurofibromin 2 (Merlin)IBA
01/2022
1brolucizumabIBA
01/2022
1afliberceptIBA
01/2022
1Tumor Necrosis Factor InhibitorsIBA
09/2021
1EnalaprilFDA LinkGeneric
01/2020
1Interferon beta-1aFDA Link
10/2018

Therapy/Procedure

23Therapeutics
02/2024 - 07/2007
13Activities of Daily Living (ADL)
05/2016 - 01/2010
9Transdermal Patch
12/2011 - 06/2009
4Injections
03/2021 - 01/2018
2Biological Therapy
05/2022 - 01/2017
1Photochemotherapy (Photodynamic Therapy)
10/2023
1Drug Therapy (Chemotherapy)
10/2023
1Ventriculoperitoneal Shunt
01/2022